Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Debourdeau

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2019
Factors influencing patient's perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational studyP Debourdeau, P Arvers, A Hij, et al.
La Revue De Medecine Interne|February 16, 2005
[Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients]M Pavic, P Sève, C Malcus, et al.
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]J P Lotz, F Pène, C Bouleuc, et al.
ESMO Open|September 5, 2021
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX studyK Klinghammer, J Fayette, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2009
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working groupP Debourdeau, D Kassab Chahmi, G Le Gal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Journal Des Maladies Vasculaires|February 19, 2010
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]P Mismetti, J-M Baud, F Becker, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2019
Factors influencing patient's perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational studyP Debourdeau, P Arvers, A Hij, et al.
La Revue De Medecine Interne|February 16, 2005
[Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients]M Pavic, P Sève, C Malcus, et al.
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]J P Lotz, F Pène, C Bouleuc, et al.
ESMO Open|September 5, 2021
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX studyK Klinghammer, J Fayette, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2009
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working groupP Debourdeau, D Kassab Chahmi, G Le Gal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Journal Des Maladies Vasculaires|February 19, 2010
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]P Mismetti, J-M Baud, F Becker, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Pageof 7